Effects of Chronic Pain Medications on Cardiovascular Health: A Narrative Review
Abstract
Cardiovascular disease (CVD) and chronic pain are leading causes of morbidity and functional disability worldwide, and there is increasing evidence demonstrating that chronic pain may elevate the risk for major adverse cardiac and cerebrovascular events. Given the intertwined nature of the cardiovascular and pain regulatory systems, medications used for chronic pain management may also contribute to the risk of cardiac events due to their cardiovascular side effects. This literature review critically evaluates the impact of the most commonly prescribed pain medications on the cardiovascular system. Medications discussed include non-steroidal anti-inflammatory drugs (NSAIDS), acetaminophen, opioids, antidepressants, gabapentinoids, and intra-articular injections. In each case, factors such as dosage and patient predispositions are considered in how they change a clinician's response in order to achieve the best patient outcome. A comprehensive literature search was performed on multiple databases, including PubMed, Google Scholar, and ScienceDirect, up to April 2026. For each drug class, cardiovascular risk was evaluated in the context of dosage and patient-specific predisposing factors, and weighed against the degree of pain relief provided. By drawing attention to this issue, our aim is to enhance understanding of drug mechanisms and identify appropriate treatment options, ultimately fostering better clinical practices and evidence-based initiatives in this healthcare…
Read the paper
Related studies
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
- Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
- Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons aged 70 and over: findings from a randomized controlled trial
- Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial
- Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.